Effect of a price transparency intervention in the electronic health record on clinician ordering of inpatient laboratory tests: The PRICE randomized clinical trial
Sedrak MS, Myers JS, Small DS, Nachamkin I, Ziemba JB, Murray D, Kurtzman GW, Zhu J, Wang W, Mincarelli D, Danoski D, Wells BP, Berns JS, Brennan PJ, Hanson CW, Dine CJ, Patel MS. JAMA Internal Medicine. 2017. Published online April 21 | doi:10.1001/jamainternmed.2017.1144
Summary
The Division of Laboratory Medicine took part in a clinical trial on reducing unnecessary testing and the high costs associated with them in healthcare. A new study, led by Penn Medicine researchers and The Wharton School and published in JAMA Internal Medicine, now finds that that simply displaying the Medicare allowable fees in EHR did not have an overall impact on how clinicians ordered these tests.
Read the Department of Communications news release.
